Deep Medicine Acquisition Stock Shares Owned By Institutions
| DMAQDelisted Stock | USD 11.59 0.12 1.02% |
Deep Medicine Acquisition fundamentals help investors to digest information that contributes to Deep Medicine's financial success or failures. It also enables traders to predict the movement of Deep Stock. The fundamental analysis module provides a way to measure Deep Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Deep Medicine stock.
Deep |
Deep Medicine Acquisition Company Shares Owned By Institutions Analysis
Deep Medicine's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Deep Medicine Shares Owned By Institutions | 28.73 % |
Most of Deep Medicine's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Deep Medicine Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
CompetitionBased on the latest financial disclosure, 28.728% of Deep Medicine Acquisition are shares owned by institutions. This is 3.4% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The shares owned by institutions for all United States stocks is 26.73% higher than that of the company.
Deep Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Deep Medicine's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Deep Medicine could also be used in its relative valuation, which is a method of valuing Deep Medicine by comparing valuation metrics of similar companies.Deep Medicine is currently under evaluation in shares owned by institutions category among its peers.
Deep Fundamentals
| Return On Asset | -0.0176 | |||
| Current Valuation | 15.74 M | |||
| Shares Outstanding | 4.36 M | |||
| Shares Owned By Insiders | 74.08 % | |||
| Shares Owned By Institutions | 28.73 % | |||
| Number Of Shares Shorted | 10.3 K | |||
| Price To Book | 22.01 X | |||
| EBITDA | (3.99 M) | |||
| Net Income | (400.23 K) | |||
| Cash And Equivalents | 707.98 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 1.86 M | |||
| Current Ratio | 229.55 X | |||
| Book Value Per Share | (1.69) X | |||
| Cash Flow From Operations | (1.04 M) | |||
| Short Ratio | 0.33 X | |||
| Earnings Per Share | (0.13) X | |||
| Beta | 0.017 | |||
| Market Capitalization | 12.9 M | |||
| Total Asset | 9.78 M | |||
| Retained Earnings | (6.44 M) | |||
| Working Capital | 6.98 M | |||
| Z Score | 2.74 | |||
| Net Asset | 9.78 M |
About Deep Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Deep Medicine Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deep Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deep Medicine Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Deep Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Deep Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deep Medicine will appreciate offsetting losses from the drop in the long position's value.Moving against Deep Stock
| 0.86 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.86 | BKRKY | Bank Rakyat | PairCorr |
| 0.84 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.83 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.73 | PPERF | Bank Mandiri Persero | PairCorr |
The ability to find closely correlated positions to Deep Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Deep Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Deep Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Deep Medicine Acquisition to buy it.
The correlation of Deep Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Deep Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Deep Medicine Acquisition moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Deep Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Deep Stock
If you are still planning to invest in Deep Medicine Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deep Medicine's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| CEOs Directory Screen CEOs from public companies around the world |